ERAN BLAUGRUND;GROSS AVIVA;MAYK ADI;TEVA PHARMACEUTICAL INDUSTRIES LTD.;CHERYL FITZER-ATTAS;ELIAZ ROM E
发明人:
CHERYL FITZER-ATTAS,ERAN BLAUGRUND,ELIAZ ROM E,GROSS AVIVA,MAYK ADI
申请号：
IL23704115
公开号：
IL237041D0
申请日:
2015.02.01
申请国别(地区):
IL
年份:
2015
代理人:
摘要：
This application provides a method of preferentially inhibiting monoamine oxidase A (MAOA) in the brain of a subject relative to in the intestine of the subject comprising parenterally administering to the subject a controlled release formulation comprising a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt thereof.
